#immunotherapy — Thursday, February 12, 2026 (2 items)
| 0 | 💬 0 |
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.
(nejm.org)
|
New England Journal of Medicine 2026-02-12 | #antibody #immunotherapy #nephropathy #cytokine #immunoglobulin | |
| 0 | 💬 0 |
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy.
(nejm.org)
|
New England Journal of Medicine 2026-02-12 | #clinical trial #immunotherapy #nephropathy #immunology |